Director Patrick Allen buys 10,000 shares of ARXS at $28.00 as part of 6-insider buy cluster post-IPO.
Patrick Allen (Director) purchased 10,000 shares at $28.00 on 2026-04-17, just 3 trading days after Arxis's recent listing, growing his position 186.7% from 5,357 to 15,357 shares for a total outlay of $280,000.00. This buy is part of a cluster pattern—6 other insiders also purchased within the past 14 days—suggesting broad insider participation in the post-IPO window. The stock has already moved to $37.65 as of 2026-04-20, reflecting a 34.5% premium over his entry price, though 52-week metrics remain non-meaningful given the 3-day trading history. The synchronized buying across multiple insiders in the immediate post-IPO period indicates that senior leadership believes the IPO pricing offered value relative to current market assessment.
CEO Jason Aaron Roth bought 60,000 shares of ARXS at $28.00; 6 other insiders also bought in 14 days
Roth purchased 60,000 shares (60.0K shares) for $1,680,000.00 ($1.7M), increasing his holdings by +17.9% to 395,515 shares (395.5K shares). This transaction is significant in context: 6 other insiders also bought within the past 14 days, forming a cluster buy pattern shortly after ARXS's recent listing (3 trading days prior). The concurrent buying activity across multiple insiders within a tight 14-day window during an IPO lockup-expiration or early trading period suggests material confidence in valuation at the $28.00 entry point, particularly as the stock has moved to $37.65 as of 2026-04-20. The cluster pattern, combined with substantial position increase by a senior executive, warrants attention as a potential signal of insider conviction regarding near-term prospects.
Kevin Scott buys 53,600 shares of ARXS at $28.00; 6 other insiders also bought in past 14 days (cluster pattern).
Kevin Scott purchased 53,600 shares at $28.00 on 2026-04-17, expanding his holdings to 3,573,133 shares post-transaction. The transaction is part of a coordinated pattern: 6 other insiders also bought within the past 14 days, forming a cluster buy signal. The stock has recently listed and currently trades at $37.65 (as of 2026-04-20), creating limited price-action history for comparative assessment. The convergence of multiple insider purchases shortly after listing, combined with Scott's substantial acquisition volume, indicates broad insider confidence during the company's early public market phase.
Director Oetgen bought 25,000 shares of ARXS at $28.00 ($700.0K); part of 6-insider cluster buy pattern post-IPO.
Stephen Duane Oetgen, a Director at Arxis, Inc., purchased 25,000 shares at $28.00 on 2026-04-17, increasing his holdings from 5,357 shares to 30,357 shares (+466.7% vs pre-transaction holdings). The transaction occurred just 3 trading days after the stock's recent listing. This purchase is part of a cluster pattern: 6 other insiders also bought within the past 14 days, suggesting synchronized board or management-level accumulation immediately following the IPO. The stock has since moved to $37.65 as of 2026-04-20, but meaningful performance context is limited given the very recent listing. The coordinated buying pattern across multiple insiders in the immediate post-IPO window merits attention as an indicator of insider confidence at the IPO pricing level.
Sealfon Ross Bradley bought 12,500 shares of Arxis at $28.00; 6 other insiders also bought within 14 days—cluster buy pattern post-IPO.
Sealfon Ross Bradley purchased 12,500 shares at $28.00 on 2026-04-17, bringing holdings to 1,102,807 shares, just three trading days after Arxis's recent listing. The transaction carries particular weight because six other insiders also bought within the past 14 days, establishing a coordinated cluster-buy pattern during the early trading phase. The current price of $37.65 reflects a 34% move from the transaction price, though this timing is too recent to constitute meaningful price performance data. The confluence of multiple insider purchases in the immediate post-listing window suggests alignment among the insider group at the opening valuation.
Arxis insider Badakhsh Azad Sid bought 36,000 shares at $28.00; 6 other insiders also bought within 14 days
Badakhsh Azad Sid purchased 36,000 shares at $28.00 for $1,008,000.00, increasing holdings from 367,864 to 403,864 shares. The material cluster context is critical here: 6 other insiders have also bought within the past 14 days, indicating a coordinated pattern of insider accumulation rather than isolated activity. The stock is trading at $37.65 as of 2026-04-20, only 3 trading days after the transaction, which is too early to assess meaningful price context given the recent listing. The clustering of purchases across multiple insiders within a narrow 14-day window is the dominant signal and warrants investor attention as a potential indicator of internal confidence in the company's prospects at this early stage of public trading.
Chief Accounting Officer Ryan Anthony Jankowski bought 4,464 shares of ARXS at $28.00 on 2026-04-17; 6 other insiders also bought within 14 days.
Jankowski, the Chief Accounting Officer, purchased 4,464 shares at $28.00, increasing his post-transaction holdings to 51,331 shares (+9.5% vs pre-transaction holdings). The transaction occurred just 3 trading days after ARXS listed, and notably, 6 other insiders also purchased shares within the past 14 days, creating a coordinated cluster buy pattern at a newly public company. This multi-insider accumulation during the early post-listing period suggests confidence from the executive team at a critical juncture for the company. The current price of $37.65 reflects early trading momentum above the insider purchase price, though the recency of listing means longer-term valuation context is not yet available.
Add ARXS to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
